Xaar Share Price. XAR - Stock Quote, Charts, Trade History, Share Chat, Financials. Xaar Plc

Gold vs US Dollar

LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.

Home
Investing
Stocks
UK
LSE
Xaar Plc (XAR)
Xaar Plc (XAR) Share Price

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Xaar Plc	LSE:XAR	London	Ordinary Share	GB0001570810	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-2.00	-1.14%	174.00	96,046	16:35:05

Bid Price		Offer Price	High Price	Low Price	Open Price
170.50		173.50	173.50	173.50	173.50

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Printing Diversified	72.78	1.63	2.10	88.00	136.34

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:37:29	O	25,000	173.50	GBX

Related Shares
Keywords Studios (KWS), Gamma Communications (GAMA), Nanosynth (NNN), Trackwise Designs (TWD)

Xaar (XAR) Latest News

Xaar News

Date	Time	Source	Headline
01/6/2023	10:37	UKREG	Xaar PLC Total Voting Rights
31/5/2023	11:30	UKREG	Xaar PLC Result of AGM
31/5/2023	09:00	UKREG	Xaar PLC Board Changes
11/5/2023	17:41	UKREG	Xaar PLC Holding(s) in Company
10/5/2023	15:10	UKREG	Xaar PLC Director/PDMR Shareholding
02/5/2023	12:39	UKREG	Xaar PLC Total Voting Rights
24/4/2023	13:05	UKREG	Xaar PLC Annual Financial Report
03/4/2023	16:51	UKREG	Xaar PLC Total Voting Rights
28/3/2023	12:09	ALNC	Xaar revenue up by quarter; 2023 revenue to meet expectations
28/3/2023	10:17	ALNC	SMALL-CAP WINNERS & LOSERS: 888's William Hill to pay record fine

Xaar Investors Xaar Takeover Rumours

Xaar (XAR) Discussions and Chat

Xaar Forums and Chat

Date	Time	Title	Posts
02/5/2023	11:22	XAAR - 2006 & Beyond	4,908
12/2/2020	13:10	XAAR	2
17/12/2014	15:44	Tip TV Daily market Round-up	-
28/8/2014	14:44	XAAR 2004 - MAJOR RECOVERY IN PROGRESS	1,081
08/12/2005	13:36	A GOOD TIME HAS BEEN HAD BY ALL BUT IS IT NOW TIME TO BANK AND BAIL?????	20

Add a New Thread

Xaar (XAR) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
15:51:49	173.50	25,000	43,375.00	O
15:37:29	174.00	3,015	5,246.10	AT
15:35:16	174.00	3,485	6,063.90	AT
15:35:16	174.00	3,500	6,090.00	AT
15:35:16	174.00	9,515	16,556.10	AT

View all Xaar trades in real-time

Xaar (XAR) Top Chat Posts

Top Posts
Posted at 20/4/2023 11:39 by simmsc opinions appear to be really split on this stock. possibly as it has some growth elements in there and it also has some recovery elements to it - which make it a bit of a hybrid stock. I share napoleons view that this will go ballistic at some stage as this will very much be a needed technology for those who want to stay in the game. Once their competitors integrate (or switch back to) Xaar's print technology, the others will have to switch. Purely just from a lead time prospective alone (let alone all the other benefits that come with it - cost, quality, efficiency, ESG credentials, etc). Sit tight and hold, possibly also buy on dips at these lower prices (if you dont have a full position in it yet). Read Full Thread Follow Reply
Posted at 08/4/2023 22:00 by napoleon 14th This share is primed to go balistic IMO. I bought in H3'20, now up 140%. SCSW like them - 30p eps anticipated in 2025 = P/E of 6.66666. If 30p eps, a P/E of 20 = 600p. "Small Caps Live Weekly" were far more stingy. I usually enjoy their "acid test" analysis but IMO they got this one wrong. They say "The EPS consensus of 3.02p does look achievable given the acquisitions, but this is a forward P/E of 60 and a PEG of over 2. This is still below 2021 EPS tho, so should this really be on a growth rating? Something like 10x forward earnings, or around 30p, would seem to be fair value here, given the very patchy track record." but nowt about successful reorg. & sales prospects. I bought on a 5 year view... Should easially double from here. Read Full Thread Follow Reply
Posted at 13/3/2023 14:22 by gargoyle2 Tipped in SCSW at the weekend -- 'I think XAR is set to become a big BUY in the latter part of the year but looking at its history, it could easily surprise positively sooner.' Read Full Thread Follow Reply
Posted at 25/1/2023 13:03 by napoleon 14th Up 100%+ after 2.5 years in XAR, but greed and realism tell me to keep until £5. Read Full Thread Follow Reply
Posted at 12/1/2023 16:52 by dr biotech Simon Thompson of the IC calls it a sell. https://www.investorschronicle.co.uk/ideas/2023/01/12/time-to-bank-a-388-per-cent-paper-gain/ ...cost inflation (labour and energy) is having an impact, too, prompting analysts at Progressive Equity to downgrade their 2023 pre-tax profit and earnings per share (EPS) forecasts by 44 per cent to £2.5mn and 3.2p, respectively, on revenue of £79.6mn (3 per cent downgrade)... group net cash fell by a third to £8.6mn in the second half of 2022, although analysts expect it to recover to £11.3mn by the end of 2023. Although management is making the right strategic moves...there is no avoiding the short-term headwinds, nor the scale of the earnings downgrade. Bank the 388 per cent paper profit. Sell. Read Full Thread Follow Reply
Posted at 20/9/2022 09:20 by brucie5 No comment? These look pretty good to me. Summary of results for the six months ended 30 June 2022: 2022 2021(1) Change Continuing Operations ---------- ---------- ------ Revenue GBP36.6m GBP26.3m +39% ---------- ---------- ------ Gross profit GBP14.5m GBP8.3m +75% ---------- ---------- ------ Gross margin % 40% 31% +9ppts ---------- ---------- ------ Gross R&D investment GBP3.3m GBP2.6m +27% ---------- ---------- ------ Adjusted EBITDA(2) GBP3.0m GBP0.3m ---------- ---------- ------ Adjusted profit/(loss) GBP1.4m (GBP1.6m) before tax(2) ---------- ---------- ------ Loss before tax (GBP0.3m) (GBP1.4m) ---------- ---------- ------ Profit/(loss) for the GBP0.7m (GBP1.3m) period after tax ---------- ---------- ------ Basic earnings per share 0.9p (1.6p) ---------- ---------- ------ Total Operations ---------- ---------- ------ Loss before tax (GBP0.6m) (GBP4.2m) +85% ---------- ---------- ------ Profit/(loss) for the period after tax GBP0.4m (GBP4.3m) +108% ---------- ---------- ------ Basic earnings per share 0.5p (3.8p) +112% ---------- ---------- ------ Net cash at the period end(3) GBP12.7m GBP17.1m -26% ---------- ---------- ------ Read Full Thread Follow Reply
Posted at 24/7/2022 13:23 by brucie5 Well, yes and no. A stonkingly high PE can also be evidence of an overvalued share price. It really depends on growth in those earnings, hence Slater's interest in PEG ratio. But the case for XAR, I believe, having listened to CR, is its reinvention on basis of its IP larder, and potential demand for its new aquieous ink product, with enhanced ESG. Read Full Thread Follow Reply
Posted at 15/7/2022 09:44 by se81 and more commentary from Progressive today after the update yesterday (Paid for "research" of course but a good way for the co to communicate with investors outside scheduled updates) Xaar’s H1 trading update for 6M ended 30th June 2022, issued yesterday, confirms that the group is trading well, with increased revenues, improving margins, costs under control and new products launching to schedule. Xaar is clearly back onto a robust growth trajectory. We are maintaining our forecasts and look forward to the interims in September as an opportunity find out more about how the momentum is building. ▪ Revenues and profits growth in line with expectations - The statement confirms that after a strong H1, performance for the full year at PBT level is seen as being in line with expectations. Revenues for H1 are expected to be approx. £37m – 41% up YoY and 14% up on an organic basis before the FFEI and Megnajet. The strong revenue growth has been accompanied by increased gross margins and effective actions on costs. ▪ Investment continues – Net Cash as at 30th June was £12.6m, down from the year end figure of £15.3m. This is consistent with our forecasts, given the acquisition of Megnajet, the ongoing capital investments and the requirement to increase working capital to protect Xaar from supply chain issues and to ensure that customers’ requirements are met. ▪ Trading encouraging on all fronts - The core printhead division has traded well, with European and US growth offsetting the Covid related slowdown in China. The product print business, eps, has seen both revenue and margin growth. ▪ Product development going to plan - The statement confirms that not only has trading performance been good, but so has progress with new product development. A new printbar product was launched in H1 by FFEI, but most importantly the company remains on track to launch the much-anticipated aqueous printhead product in Q4 2022. ▪Price increases, not just cost cutting - The statement refers to management actions to mitigate the impact of cost increases – not least of which is the fact that Xaar has successfully put through sales price increases. This is a timely and reassuring reminder that it has products, skills and technologies that customers value and are willing to pay up for. Xaar offers investors a clear, understandable tech growth story with a near $1bn addressable market opportunity and a management team that is demonstrating its ability to execute. We continue to question whether the value of this combination is fully reflected in the share price. Read Full Thread Follow Reply
Posted at 22/6/2022 07:43 by se81 Progressive out with a new (free) note this morning....some interesting stuff in there (re the business, products, future growth etc)- headline summary below With a clear roadmap of new digital inkjet products and an ambitious management team focused on gaining (or retaining) significant market shares across the segments that make up its $1bn addressable market, Xaar is positioned to grow strongly. Management has already demonstrated its abilities in turning the business around, and we believe it is far from clear that the share price fully reflects the opportunities ahead. ▪ $1bn market awaits. The market for industrial digital inkjet printheads is estimated by management to be approaching $1bn per annum. Xaar’s product roadmap suggests that it will be able to address the vast majority of this within a few years. If the management team delivers on the product roadmap, Xaar will be well-positioned to take a strong share of these markets. ▪ Clear signs of progress. Management has a strategy in place to drive revenue back up by launching new products and adopting a revised approach to customers and the channel. Improving revenues and a growing number of customer products both in development and in the market show that management is already delivering on this strategy. ▪ Profit and cashflow upside. The high gross margin and relatively fixed cost base mean that as product and revenue traction build, the impact on the bottom line will be geared upwards. On top of this, the significant historical capital investment means that material increases in output can be achieved for limited capital outlay: a possible positive profit and cashflow double whammy. ▪ ESG potential. Management believes that Xaar can reduce overall ink and energy consumption, most notably with the launch of its aqueous ink capable printheads, which use significantly less water than standard printheads and save on the heat energy used to dry the inks. Starting from £40m revenue in printheads in FY21, a near $1bn addressable market opportunity and a management team that has shown itself able to execute, even though the shares are on premium multiples, the market valuation appears that it may not fully reflect the scale of Xaar’s potential revenue and profit growth. Xaar offers investors a clear, understandable technology growth story, building on an established set of technologies providing solutions across a range of demanding printing applications. Read Full Thread Follow Reply
Posted at 28/4/2022 10:05 by tomps2 XAR pitched in the latest episode of Sell It To The City Richard Crow pitches Xaar (XAR) to leading fund managers, Andy Brough, Judith MacKenzie and Stephen English at 2m20s in the latest PIWORLD Sell It To The city. Watch the video here: www.piworld.co.uk/education-videos/sell-it-to-the-city-april-2022/ Or listen to the podcast here: piworld.podbean.com/e/sell-it-to-the-city-april-2022/ Read Full Thread Follow Reply

Xaar share price data is direct from the London Stock Exchange

Your Recent History

LSE

XAR

Xaar

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea

V: D: 20230602 21:08:04